“Coeptis Therapeutics (COEP) is excited to announce its rebranding to Coeptis, marking a transformative shift in its business strategy. This pivotal change reflects our commitment to expanding beyond biopharmaceuticals and embracing diverse growth opportunities in technology-driven sectors. With the establishment of our new Technology Division, Coeptis aims to enhance operational capabilities and maximize shareholder value. Central to this initiative was the recent acquisition of the NexGenAI Affiliates Network platform, a groundbreaking AI-powered marketing solution. This acquisition aligns seamlessly with Coeptis’s mission to innovate in highly regulated industries, revolutionizing marketing strategies and operational efficiencies.”
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COEP:
- Coeptis Therapeutics Holdings Inc trading resumes
- Coeptis Therapeutics Holdings Inc trading halted, volatility trading pause
- Coeptis Therapeutics regains compliance with Nasdaq listing rules
- Coeptis Therapeutics Holdings Inc trading halted, news pending
- Upcoming Stock Splits This Week (December 30 to January 3) – Stay Invested